China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-08-27 12:07 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, China, Law & Courts, Drugs, Business & Economy, Crime & Justice, Asia Pacific
--------------------------------------------------------------------
Snippet:
The biliary tract cancer trial is the latest breakthrough for Akeso’s ivonescimab, which has also shown promise in treating some lung cancers
--------------------------------------------------------------------
>>> Read full article at South China Morning Post <<<
<-- Back to Home
< >
[Close]